A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world.
Amgen has developed a collection of online resources available to help you learn more about areas of interest.
Do you want to link to this External Site and leave Amgen.com?
YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.
Amgen Announces Positive Topline Phase 2 Results for Investigational KRAS G12C Inhibitor Sotorasib in Advanced Non-Small Cell Lung Cancer View Press Release
Check here for Amgen updates, Amgen product information, public health resources, and other pertinent information related to COVID-19.
Signs of steady growth and other findings from Amgen's 2020 Biosimilar Trends Report
Bradway Speaks at Financial Times Conference
Amgen CEO Bob Bradway will join leading voices on healthcare inequity at the Amgen Health Equity Summit.
Reimagining Science Education for All
Invented by Berkeley Lights and developed with early input from Amgen, digital cell biology has immediate applications and abundant long-term potential.
At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from diseases. Amgen believes the cure for disease can be found inside each and every one of us.
If you're seeking a career where you can truly make a difference in the lives of others, where you can work at the forefront of biotechnology with the top minds in the field, you'll find it at Amgen.
Amgen and the Amgen Foundation inspire the next generation of innovators by funding science education programs at every level, from local high schools to the world’s premier educational institutions. It’s all part of Amgen’s commitment to fuel science innovation and create a brighter, healthier future for all.
Find out what it takes to deliver biotechnology medicines to patients.
Amgen has developed a robust and differentiated pipeline, leveraging state-of-the-art science to create medicines for serious illnesses.